🇦🇺 Australia Country × Condition
solid tumor Clinical Trials in Australia
Active clinical trials for solid tumor with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT05923008 Phase 1, Phase 2
Recruiting
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Enrollment
182 pts
Country
🇦🇺 Australia
Innovent Biologics (Suzhou) Co. Ltd...
View Trial → NCT06234423 Phase 1
Recruiting
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Enrollment
263 pts
Country
🇦🇺 Australia
OnCusp Therapeutics, Inc.
View Trial → NCT05269316 Phase 1, Phase 2
Recruiting
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Enrollment
61 pts
Country
🇦🇺 Australia
Impact Therapeutics, Inc.
View Trial → Frequently Asked Questions
How many solid tumor clinical trials are active in Australia?
There are currently 3 active clinical trials for solid tumor with sites in Australia, of which 3 are actively recruiting patients.
How can I join a solid tumor clinical trial in Australia?
To join a solid tumor clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are solid tumor trials in Australia?
Active solid tumor trials in Australia span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.